IMA welcomes the Food and Drug Administration’s decision to expand its internal review of potential COVID-19 vaccine–related deaths to include adults.
“For too long, legitimate safety questions have been brushed aside rather than openly evaluated,” said Dr. Joseph Varon, IMA President and Chief Medical Officer. “Our position has always been consistent: follow the evidence, investigate credible signals, and be honest with the American public. If the FDA is now willing to review adult cases with the seriousness they deserve, that is a welcome and necessary development.”
Please have a read here. As Dr. Mollie James said in last night’s webinar, “This should’ve have happened four years ago.” It has eventually, though. Have a read, and please add your thoughts.